📊 Removal Estimates

Estimates based on drug properties and standard treatment parameters.

🩸

42.7 mL/min

Moderately Dialyzable

Some removal expected. Monitor drug levels.

Data Used:
✅ protein_binding, molar_mass, mw_factor, vd, vd_factor
⚠️ Missing: half_life

Free fraction: 0.79 Mw factor: 1 Vd factor: 0.2 Hl factor: 1 Half life: N/A Half life category: Unknown

🫀

5.2 mL/min

Moderate PD Clearance

Some removal possible, but likely not clinically significant.

Data Used:
✅ protein_binding, molar_mass
⚠️ Missing: half_life

Free fraction: 0.79 Half life: N/A Half life category: Unknown

🔄

Low Risk

This drug is unlikely to be significantly removed by TPE.

Data Used:
✅ protein_binding, vd
⚠️ Missing: half_life

Half life: N/A Half life category: Unknown

🧪

Low Effectiveness

Poor candidate for hemoperfusion. Drug is distributed in tissues.

Data Used:
✅ vd
⚠️ Missing: half_life

Half life: N/A Half life category: Unknown

Modality	Clearance/Value	Half-Life	Classification	Data Quality
Hemodialysis	42.7 mL/min	N/A	Moderately Dialyzable	Partial Data
Peritoneal Dialysis	5.2 mL/min	N/A	Moderate PD Clearance	Partial Data
Plasmapheresis (TPE)	Low Risk	N/A	N/A	Partial Data
Hemoadsorption	Low Effectiveness	N/A	N/A	Partial Data

Hemodialysis: Estimates based on high-flux dialyzer (urea clearance 270 mL/min), Qb 300 mL/min, 4-hour session.
Peritoneal Dialysis: Estimates based on CAPD (Continuous Ambulatory Peritoneal Dialysis).
TPE: Risk assessment based on protein binding and volume of distribution.
Hemoadsorption: Effectiveness based on volume of distribution. Most effective for drugs with Vd < 0.2 L/kg.
Data Quality: Estimates with missing data use default assumptions. Consider adding missing data for more accurate predictions.
Clinical Note: These are descriptive estimates only. Always consult clinical guidelines and monitor drug levels when available.